Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2025-12-24 @ 7:07 PM
NCT ID:
NCT04460157
Eligibility Criteria:
Inclusion Criteria:
* Had achieved SVR 12 weeks after DAA-based regimen, either with or without Peg-interferon
* Showed liver stiffness (LS) value ≥9.5 kPa prior to treatment
* Had LS measurement available at SVR time-point
Exclusion Criteria:
* Individuals seropositive for HBsAg
* Individuals who refuse to participate
* Individuals under 18 years old
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04460157
Study Brief:
Protocol Section:
NCT04460157